EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Current Overview of Metal Nanoparticles’ Synthesis, Characterization, and Biomedical Applications, with a Focus on Silver and Gold Nanoparticles

Ana Flavia Burlec, Andreia Corciova iD, Monica Boev, Denisa Batir-Marin, Cornelia Mircea, Oana Cioanca iD, Gabriela Danila, Marius Danila, Anca Florentina Bucur, Monica Hancianu

Pharmaceuticals · 04.10.2023 · 16 (10) · 1410

DOI: 10.3390/ph16101410 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 04.10.2023. Verfasst von Ana Flavia Burlec und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, "Grigore T. Popa" University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania. Die Arbeit wurde bisher 305-mal zitiert (Crossref) und nennt 370 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metal nanoparticles (NPs) have garnered considerable attention, due to their unique physicochemical properties, that render them promising candidates for various applications in medicine and industry. This article offers a comprehensive overview of the most recent advancements in the manufacturing, characterization, and biomedical utilization of metal NPs, with a primary focus on silver and gold NPs. Their potential as effective anticancer, anti-inflammatory, and antimicrobial agents, drug delivery systems, and imaging agents in the diagnosis and treatment of a variety of disorders is reviewed. Moreover, their translation to therapeutic settings, and the issue of their inclusion in clinical trials, are assessed in light of over 30 clinical investigations that concentrate on administering either silver or gold NPs in conditions ranging from nosocomial infections to different types of cancers. This paper aims not only to examine the biocompatibility of nanomaterials but also to emphasize potential challenges that may limit their safe integration into healthcare practices. More than 100 nanomedicines are currently on the market, which justifies ongoing study into the use of nanomaterials in medicine. Overall, the present review aims to highlight the potential of silver and gold NPs as innovative and effective therapeutics in the field of biomedicine, citing some of their most relevant current applications.

Schlagwörter

Stichwörter der Autor:innen

anticancer activityantimicrobial activitybiological synthesisclinical trialsinorganic nanoparticles

Autor:innen und Institutionen

  • Faculty of Pharmacy, "Grigore T. Popa" University of Medicine and Pharmacy Iasi, 700115 Iasi, Romania.
  • Research Centre in the Medical-Pharmaceutical Field, Faculty of Medicine and Pharmacy, "Dunarea de Jos" University of Galati, 800008 Galati, Romania.

ORCID-Profile: Andreia Corciova, Oana Cioanca

Zitieren

APA

Burlec, A. F., Corciova, A., Boev, M., Batir-Marin, D., Mircea, C., Cioanca, O., Danila, G., Danila, M., Bucur, A. F., & Hancianu, M. (2023). Current Overview of Metal Nanoparticles’ Synthesis, Characterization, and Biomedical Applications, with a Focus on Silver and Gold Nanoparticles. Pharmaceuticals, 16(10), 1410. https://doi.org/10.3390/ph16101410

Vancouver

Burlec AF, Corciova A, Boev M, Batir-Marin D, Mircea C, Cioanca O, et al. Current Overview of Metal Nanoparticles’ Synthesis, Characterization, and Biomedical Applications, with a Focus on Silver and Gold Nanoparticles. Pharmaceuticals. 2023;16(10):1410. doi:10.3390/ph16101410

BibTeX
@article{Burlec2023,
  author = {Burlec, Ana Flavia and Corciova, Andreia and Boev, Monica and Batir-Marin, Denisa and Mircea, Cornelia and Cioanca, Oana and Danila, Gabriela and Danila, Marius and Bucur, Anca Florentina and Hancianu, Monica},
  title = {Current Overview of Metal Nanoparticles’ Synthesis, Characterization, and Biomedical Applications, with a Focus on Silver and Gold Nanoparticles},
  journal = {Pharmaceuticals},
  year = {2023},
  volume = {16},
  number = {10},
  pages = {1410},
  doi = {10.3390/ph16101410}
}
Kostenlos starten →